One month of non-invasive vagus nerve stimulation (nVNS), administered at home using a hand-held device by electroCore, improved walking and motor abilities, and eased freezing of gait in adults with Parkinson’s disease, according to data from a small clinical trial.
ElectroCore’s nVNS device, called gammaCore Sapphire, is approved in the U.S. and Europe for the treatment of migraines and headaches. Designed as a portable and easy-to-use technology, gammaCore can be self-administered by patients by placing the device over the vagus nerve in their neck.
A prescription is required. Cost appears to be between $1,250 and $1,750 USD.